JavaScript not detected: JavaScript is required to run this site. Please enable JavaScript in your browser's settings.

Hearing: Examining FDA’s Prescription Drug User Fee Program

Subcommittee on Health (Committee on Energy and Commerce)

Wednesday, March 22, 2017 (10:15 AM)

2322 RHOB
Washington, D.C.

Witnesses

Dr. Janet Woodcock
Director, Food and Drug Administration, Center for Drug Evaluation and Research

Added 03/21/2017 at 02:13 PM

Mr. Jeff Allen
President and CEO, Friends of Cancer Research

Added 03/21/2017 at 02:13 PM

Ms. Kay Holcombe
Senior Vice President of Science Policy, Biotechnology Industry Organization

Added 03/21/2017 at 02:13 PM

Dr. Anne Pritchett
Vice President of Policy and Research, Pharmaceutical Research and Manufacturers of America

Added 03/21/2017 at 02:13 PM

Hearing Notice [PDF] Added 03/15/2017 at 04:01 PM
Background Memo [PDF] Added 03/20/2017 at 09:57 AM
Document for the Record - Rep. Burgess - NVCA Article [PDF] Added 05/19/2017 at 05:32 PM
Document for the Record - Rep. Burgess - RDLA Article [PDF] Added 05/19/2017 at 05:32 PM
Document for the Record - Rep. Burgess - Friends of Cancer Research Article [PDF] Added 05/19/2017 at 05:32 PM
Document for the Record - Rep. Burgess - Epilepsy Foundation Letter [PDF] Added 05/19/2017 at 05:32 PM

Opening Statement - Health Subcommittee Chairman Michael C. Burgess [PDF] Added 03/29/2017 at 11:12 AM
Opening Statement - Full Committee Ranking Member Pallone [PDF] Added 05/19/2017 at 05:32 PM

First Published: March 15, 2017 at 03:55 PM
Last Updated: May 19, 2017 at 05:32 PM